Huang Jinbao, Li Hongyan, Chen Shuxing, Lan Changqing, Lin Qinghua, Weng Heng
Department of Respiratory and Critical Care Medicine.
Department of Thoracic Surgery.
Medicine (Baltimore). 2019 May;98(20):e15661. doi: 10.1097/MD.0000000000015661.
At present, data regarding refractory pneumothorax treated with video-assisted thoracic surgery (VATS) in combination with extracorporeal membrane oxygenation (ECMO) in critically ill patients with H7N9 pneumonia have never been reported.
A laboratory-confirmed case of human infection with avian influenza A (H7N9) virus was treated in our hospital. Acute respiratory distress syndrome (ARDS) developed and the patient was oxygenated via veno-venous ECMO due to the failure of mechanical ventilation. Unfortunately, a right refractory pneumothorax occurred. Despite treatment with pleural drainage and select bronchial occlusion, the patient still failed to improve.
Fatal H7N9 pneumonia complicated with severe ARDS, pulmonary bullae, and refractory pneumothorax.
Successful combination of ECMO with VATS of pulmonary bullae resection was performed and pneumothorax was cured.
One week after the operation, ECMO was removed. However, the patient finally developed multiorgan failure (MOF) complicated by refractory hypoxemia due to progressive lung fibrosis and died 36 days after admission.
Although the patient died of MOF triggered by severe lung fibrosis at last, the successful treatment of refractory pneumothorax by combination of ECMO with VATS is encouraging. Thus, when refractory pneumothorax in a patient with severe pulmonary dysfunction fails to improve through routine therapy, the treatment of pneumothorax by VATS based on ECMO support can be considered as a feasible selection.
目前,关于在患有H7N9肺炎的重症患者中采用电视辅助胸腔镜手术(VATS)联合体外膜肺氧合(ECMO)治疗难治性气胸的数据从未被报道过。
我院收治了一例实验室确诊的人感染甲型H7N9禽流感病毒病例。患者出现急性呼吸窘迫综合征(ARDS),因机械通气失败而通过静脉-静脉ECMO进行氧合。不幸的是,患者发生了右侧难治性气胸。尽管进行了胸腔闭式引流和选择性支气管封堵治疗,但患者仍未改善。
致命性H7N9肺炎合并严重ARDS、肺大疱和难治性气胸。
成功地将ECMO与VATS肺大疱切除术相结合,气胸得以治愈。
术后一周,撤除了ECMO。然而,患者最终因进行性肺纤维化发展为多器官功能衰竭(MOF)并合并难治性低氧血症,入院36天后死亡。
尽管患者最终死于严重肺纤维化引发的MOF,但ECMO联合VATS成功治疗难治性气胸令人鼓舞。因此,当严重肺功能障碍患者的难治性气胸经常规治疗无效时,基于ECMO支持的VATS治疗气胸可被视为一种可行的选择。